The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies withex-vivoexpanded cells produced with the Aastrom Replicell® technology
C. Chabannon, G. Novakovitch, J.-L. Blache, S. Olivero, J. Camerlo, D. Genre, D. Maraninchi, P. ViensVolume:
41
Language:
english
Pages:
4
DOI:
10.1007/s00282-999-0078-7
Date:
April, 1999
File:
PDF, 106 KB
english, 1999